Adipose, Bone Marrow and Synovial Joint-Derived Mesenchymal Stem Cells for Cartilage Repair

Current cell-based repair strategies have proven unsuccessful for treating cartilage defects and osteoarthritic lesions, consequently advances in innovative therapeutics are required and mesenchymal stem cell-based (MSC) therapies are an expanding area of investigation. MSCs are capable of differentiating into multiple cell lineages and exerting paracrine effects. Due to their easy isolation, expansion, and low immunogenicity, MSCs are an attractive option for regenerative medicine for joint repair. Recent studies have identified several MSC tissue reservoirs including in adipose tissue, bone marrow, cartilage, periosteum, and muscle. MSCs isolated from these discrete tissue niches exhibit distinct biological activities, and have enhanced regenerative potentials for different tissue types. Each MSC type has advantages and disadvantages for cartilage repair and their use in a clinical setting is a balance between expediency and effectiveness. In this review we explore the challenges associated with cartilage repair and regeneration using MSC-based cell therapies and provide an overview of phenotype, biological activities, and functional properties for each MSC population. This paper also specifically explores the therapeutic potential of each type of MSC, particularly focusing on which cells are capable of producing stratified hyaline-like articular cartilage regeneration. Finally we highlight areas for future investigation. Given that patients present with a variety of problems it is unlikely that cartilage regeneration will be a simple “one size fits all,” but more likely an array of solutions that need to be applied systematically to achieve regeneration of a biomechanically competent repair tissue

A perspective on the impacts of microplastics on mosquito biology and their vectorial capacity

Microplastics (plastic particles <5 mm) permeate aquatic and terrestrial ecosystems and constitute a hazard to animal life. Although much research has been conducted on the effects of microplastics on marine and benthic organisms, less consideration has been given to insects, especially those adapted to urban environments. Here, we provide a perspective on the potential consequences of exposure to microplastics within typical larval habitat on mosquito biology. Mosquitoes represent an ideal organism in which to explore the biological effects of microplastics on terrestrial insects, not least because of their importance as an infectious disease vector. Drawing on evidence from other organisms and knowledge of the mosquito life cycle, we summarise some of the more plausible impacts of microplastics including physiological, ecotoxicological and immunological responses. We conclude that although there remains little experimental evidence demonstrating any adverse effect on mosquito biology or pathogen transmission, significant knowledge gaps remain, and there is now a need to quantify the effects that microplastic pollution could have on such an important disease vector

Film-forming amine product as an alternative to carbohydrazide oxygen scavenger in high pressure boilers

Hydrazine has been largely replaced by carbohydrazide (CHZ) as an oxygen scavenger due to safety and health concerns and CHZ is now used in Saline Water Conversion Corporation (SWCC) high pressure boilers. However, the operational problem of phosphate hide-out has become a continuous challenge for the plant operators. Advances in boiler water treatment have shown that effective corrosion control and prevention of scaling can be achieved by using a mixture of filmforming and alkalizing amines and polycarboxylates [Film Forming Amine Product (FFAP)]. With the use of FFAP, carbohydrazide/ammonia treatment of make-up water and phosphate treatment in the drum will not be required. A uniform FFAP formulation was used throughout the test. The evaluation study was carried out at a boiler of the Yanbu Phase 1 Desalination and Power Plant (Mitsubishi) generating 60 MWh, with make-up water of 15 t h− 1 producing 330 t h− 1 steam at a pressure of 67 barg and temperature of 480 ◦C. The trial provided evidence that FFAP was a good alternative to use of an oxygen scavenger. Changeover from CHZ to FFAP without phosphate addition in the drum was done initially by dosing FFAP from both hydrazine tank and phosphate tank so that pH was maintained to the required values in both feed water and drum water. With the optimal dose rate (0.6 ppm) maintaining FFAP in the range of 0.3–1.0 ppm in feed water, all the key parameters (pH, ammonia and specific conductivity) were within the specified boiler design limits. The average corrosion rates on the water side were low for both CHZ and FFAP treatment (0.009 ± 0.001 mm y− 1), however FFAP treated coupons showed much lower corrosion rates compared to CHZ in the steam side (0.0006 ± 0.0003 mm y− 1 cf. 0.0075 ± 0.0006 mm y− 1)

The Relationship Between Central Auditory Tests and Neurocognitive Domains in Adults Living With HIV

Objective: Tests requiring central auditory processing, such as speech perception-in-noise, are simple, time efficient, and correlate with cognitive processing. These tests may be useful for tracking brain function. Doing this effectively requires information on which tests correlate with overall cognitive function and specific cognitive domains. This study evaluated the relationship between selected central auditory focused tests and cognitive domains in a cohort of normal hearing adults living with HIV and HIV– controls. The long-term aim is determining the relationships between auditory processing and neurocognitive domains and applying this to analyzing cognitive function in HIV and other neurocognitive disorders longitudinally. Method: Subjects were recruited from an ongoing study in Dar es Salaam, Tanzania. Central auditory measures included the Gap Detection Test (Gap), Hearing in Noise Test (HINT), and Triple Digit Test (TDT). Cognitive measures included variables from the Test of Variables of Attention (TOVA), Cogstate neurocognitive battery, and Kiswahili Montreal Cognitive Assessment (MoCA). The measures represented three cognitive domains: processing speed, learning, and working memory. Bootstrap resampling was used to calculate the mean and standard deviation of the proportion of variance explained by the individual central auditory tests for each cognitive measure. The association of cognitive measures with central auditory variables taking HIV status and age into account was determined using regression models. Results: Hearing in Noise Tests and TDT were significantly associated with Cogstate learning and working memory tests. Gap was not significantly associated with any cognitive measure with age in the model. TDT explained the largest mean proportion of variance and had the strongest relationship to the MoCA and Cogstate tasks. With age in the model, HIV status did not affect the relationship between central auditory tests and cognitive measures. Age was strongly associated with multiple cognitive tests. Conclusion: Central auditory tests were associated with measures of learning and working memory. Compared to the other central auditory tests, TDT was most strongly related to cognitive function. These findings expand on the association between auditory processing and cognitive domains seen in other studies and support evaluating these tests for tracking brain health in HIV and other neurocognitive disorders

Seawater desalination concentrate—a new frontier for sustainable mining of valuable minerals

The ocean has often been announced as a sustainable source of important materials for civilization. Application of the same extraction processes to desalination concentrate, rather than to unconcentrated seawater, will necessarily be more energetically favorable, so the expansion of seawater desalination in recent decades brings this dream closer to reality. However, there is relatively little concrete commercial development of 'concentrate mining'. This review assesses the technical and economic prospects for utilization of commercially viable products from seawater. The most important technologies for economic use of products from desalination plant concentrate are technologies for more economic separation and technologies for more economic concentration. The most promising separation technologies are those, such as nanofiltration, which separate brine into streams enriched/depleted in entire classes of constituents with minimal input of energy and reagents. Concentration is becoming more economic due to rapid advances in Osmotically-Assisted RO technology. Despite very active research on many aspects of desalination concentrate utilization, it is likely that commercial development of the non-NaCl components of desalination brine will depend on the available market for NaCl, as the challenges and costs of extracting the other mineral components from bitterns in which they are highly enriched are so much less than those faced in direct treatment of brines

Ab initio RAFT emulsion polymerization mediated by small cationic RAFT agents to form polymers with low molar mass dispersity

We report on low molar mass cationic RAFT agents that provide predictable molar mass and low molar mass dispersities (Đm) in ab initio emulsion polymerization. Thus RAFT emulsion polymerization of styrene in the presence of the protonated RAFT agent, ((((cyanomethyl)thio)carbonothioyl)(methyl)amino)pyridin-1-ium toluenesulfonate (4), and the analogous methyl-quaternized RAFT agents, 4-((((cyanomethyl)thio)carbonothioyl)(methyl)amino)-1-methylpyridin-1-ium dodecyl sulfate (6), provide low dispersity polystyrene with Đm 1.2–1.4 for Mn ∼ 20 000. We postulate that the success of ab initio emulsion polymerization with 4 is due to the hydrophilicity of the pyridinium group, which is such that the water soluble RAFT agent partitions predominantly into the aqueous phase under the conditions of the experiment and that 4 provides little retardation. With 6, when the counterion is dodecyl sulfate, we can achieve “surfactant-free” RAFT emulsion polymerization to provide a low Đm polystyrene. However, the RAFT end-group is lost on isolation of the polymer. Preliminary results show that this class of RAFT agent is broadly applicable in ab initio emulsion polymerization of other more-activated monomers (e.g., butyl acrylate, butyl methacrylate). Furthermore, cyanomethyl(pyridin-4-yl)carbamodithioate (3, the RAFT agent in neutral form) provides molar mass control and Đm < 1.8 in ab initio emulsion polymerization of less activated monomers, specifically, the vinyl esters, vinyl acetate and vinyl benzoate.Published onlin

IUPAC recommended experimental methods and data evaluation procedures for the determination of radical copolymerization reactivity ratios from composition data

The IUPAC working group on “Experimental Methods and Data Evaluation Procedures for the Determination of Radical Copolymerization Reactivity Ratios” recommends a robust method to determine reactivity ratios from copolymer composition data using the terminal model for copolymerization. The method is based on measuring conversion (X) and copolymer composition (F) of three or more copolymerization reactions at different initial monomer compositions (f0). Both low and high conversion experiments can be combined, or alternatively only low conversion experiments can be used. The method provides parameter estimates, but can also reveal deviations from the terminal model and the presence of systematic errors in the measurements. Special attention is given to error estimation in F and construction of the joint confidence interval for reactivity ratios. Previous experiments measuring f0 − F or f − X can also be analyzed with the IUPAC recommended method. The influence of systematic errors in the measurements on the reactivity ratio determinations is investigated, including ways to identify and mitigate such errors

Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American society of interventional pain physicians (ASIPP) guidelines

Background: Opioid use, abuse, and adverse consequences, including death, have escalated at an alarming rate since the 1990s. In an attempt to control opioid abuse, numerous regulations and guidelines for responsible opioid prescribing have been developed by various organizations. However, the US opioid epidemic is continuing and drug dose deaths tripled during 1999 to 2015. Recent data show a continuing increase in deaths due to natural and semisynthetic opioids, a decline in methadone deaths, and an explosive increase in the rates of deaths involving other opioids, specifically heroin and illicit synthetic fentanyl. Contrary to scientific evidence of efficacy and negative recommendations, a significant proportion of physicians and patients (92%) believe that opioids reduce pain and a smaller proportion (57%) report better quality of life. In preparation of the current guidelines, we have focused on the means to reduce the abuse and diversion of opioids without jeopardizing access for those patients suffering from non-cancer pain who have an appropriate medical indication for opioid use. Objectives: To provide guidance for the prescription of opioids for the management of chronic non-cancer pain, to develop a consistent philosophy among the many diverse groups with an interest in opioid use as to how appropriately prescribe opioids, to improve the treatment of chronic non-cancer pain and to reduce the likelihood of drug abuse and diversion. These guidelines are intended to provide a systematic and standardized approach to this complex and difficult arena of practice, while recognizing that every clinical situation is unique. Methods: The methodology utilized included the development of objectives and key questions. The methodology also utilized trustworthy standards, appropriate disclosures of conflicts of interest, as well as a panel of experts from various specialties and groups. The literature pertaining to opioid use, abuse, effectiveness, and adverse consequences was reviewed, with a best evidence synthesis of the available literature, and utilized grading for recommendation as described by the Agency for Healthcare Research and Quality (AHRQ)

Terminology for chain polymerization (IUPAC Recommendations 2021)

Chain polymerizations are defined as chain reactions where the propagation steps occur by reaction between monomer(s) and active site(s) on the polymer chains with regeneration of the active site(s) at each step. Many forms of chain polymerization can be distinguished according to the mechanism of the propagation step (e.g., cyclopolymerization – when rings are formed, condensative chain polymerization – when propagation is a condensation reaction, group-transfer polymerization, polyinsertion, ring-opening polymerization – when rings are opened), whether they involve a termination step or not (e.g., living polymerization – when termination is absent, reversible-deactivation polymerization), whether a transfer step is involved (e.g., degenerative-transfer polymerization), and the type of chain carrier or active site (e.g., radical, ion, electrophile, nucleophile, coordination complex). The objective of this document is to provide a language for describing chain polymerizations that is both readily understandable and self-consistent, and which covers recent developments in this rapidly evolving field

Terminology for chain polymerization (IUPAC Recommendations 2021)

Chain polymerizations are defined as chain reactions where the propagation steps occur by reaction between monomer(s) and active site(s) on the polymer chains with regeneration of the active site(s) at each step. Many forms of chain polymerization can be distinguished according to the mechanism of the propagation step (e.g., cyclopolymerization – when rings are formed, condensative chain polymerization – when propagation is a condensation reaction, group-transfer polymerization, polyinsertion, ring-opening polymerization – when rings are opened), whether they involve a termination step or not (e.g., living polymerization – when termination is absent, reversible-deactivation polymerization), whether a transfer step is involved (e.g., degenerative-transfer polymerization), and the type of chain carrier or active site (e.g., radical, ion, electrophile, nucleophile, coordination complex). The objective of this document is to provide a language for describing chain polymerizations that is both readily understandable and self-consistent, and which covers recent developments in this rapidly evolving field